ZNF567
gene geneOn this page
Also known as MGC45586
Summary
ZNF567 (zinc finger protein 567, HGNC:28696) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 567 (Q8N184). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 163081 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 53 total
- MANE Select transcript:
NM_001322917
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28696 |
| Approved symbol | ZNF567 |
| Name | zinc finger protein 567 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC45586 |
| Ensembl gene | ENSG00000189042 |
| Ensembl biotype | protein_coding |
| Entrez | 163081 |
Gene structure
Transcript identifiers
Ensembl transcripts: 30 — 28 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000360729, ENST00000536254, ENST00000585696, ENST00000588311, ENST00000589264, ENST00000590392, ENST00000591308, ENST00000682579, ENST00000910217, ENST00000910218, ENST00000910219, ENST00000910220, ENST00000910221, ENST00000910223, ENST00000910225, ENST00000910227, ENST00000915754, ENST00000915755, ENST00000915756, ENST00000915757, ENST00000915758, ENST00000915759, ENST00000915760, ENST00000915761, ENST00000915762, ENST00000941119, ENST00000941120, ENST00000941121, ENST00000941122, ENST00000941123
RefSeq mRNA: 28 — MANE Select: NM_001322917
NM_001300979, NM_001322911, NM_001322912, NM_001322913, NM_001322914, NM_001322915, NM_001322916, NM_001322917, NM_001322918, NM_001322919, NM_001322920, NM_001363651, NM_001387759, NM_001387760, NM_001387761, NM_001387762, NM_001387763, NM_001387764, NM_001387765, NM_001387766, NM_001387767, NM_001387768, NM_001387769, NM_001387770, NM_001387771, NM_001387772, NM_001387773, NM_152603
CCDS: CCDS12495, CCDS74349, CCDS86756
Canonical transcript exons
ENST00000682579 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001258376 | 36712781 | 36712867 |
| ENSE00002937680 | 36687612 | 36687634 |
| ENSE00003578490 | 36694802 | 36694876 |
| ENSE00003668707 | 36712386 | 36712512 |
| ENSE00003916164 | 36718948 | 36721336 |
| ENSE00003918311 | 36689397 | 36689497 |
Expression profiles
Bgee: expression breadth ubiquitous, 245 present calls, max score 91.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.2309 / max 65.0649, expressed in 1104 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175523 | 2.2309 | 1104 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 91.07 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 89.56 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.35 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.21 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 81.83 | gold quality |
| ventricular zone | UBERON:0003053 | 79.63 | gold quality |
| cortical plate | UBERON:0005343 | 79.39 | gold quality |
| buccal mucosa cell | CL:0002336 | 79.27 | gold quality |
| placenta | UBERON:0001987 | 79.25 | gold quality |
| thymus | UBERON:0002370 | 79.25 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 78.78 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.51 | gold quality |
| left testis | UBERON:0004533 | 78.51 | gold quality |
| cartilage tissue | UBERON:0002418 | 78.44 | gold quality |
| right testis | UBERON:0004534 | 78.31 | gold quality |
| testis | UBERON:0000473 | 78.23 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.02 | gold quality |
| lymph node | UBERON:0000029 | 77.86 | gold quality |
| sperm | CL:0000019 | 77.45 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 77.32 | gold quality |
| skin of hip | UBERON:0001554 | 77.22 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 77.18 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.63 | gold quality |
| adrenal tissue | UBERON:0018303 | 76.41 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 76.35 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.13 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.12 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 75.95 | gold quality |
| sural nerve | UBERON:0015488 | 75.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.72 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
48 targeting ZNF567, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-3120-3P | 99.54 | 70.28 | 2669 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-4696 | 99.48 | 67.48 | 1040 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG14442 | FBGN0029893 |
| drosophila_melanogaster | CG14440 | FBGN0029894 |
Paralogs (11): IKZF2 (ENSG00000030419), ZNF821 (ENSG00000102984), ZNF639 (ENSG00000121864), IKZF4 (ENSG00000123411), ZNF382 (ENSG00000161298), IKZF3 (ENSG00000161405), ZNF613 (ENSG00000176024), IKZF1 (ENSG00000185811), ZNF649 (ENSG00000198093), ZNF564 (ENSG00000249709), ZNF350 (ENSG00000256683)
Protein
Protein identifiers
Zinc finger protein 567 — Q8N184 (reviewed: Q8N184)
All UniProt accessions (4): F8WEL6, Q8N184, K7EMD5, K7ESK1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N184-3 | 3 | yes |
| Q8N184-1 | 1 | |
| Q8N184-2 | 2 |
RefSeq proteins (28): NP_001287908, NP_001309840, NP_001309841, NP_001309842, NP_001309843, NP_001309844, NP_001309845, NP_001309846, NP_001309847, NP_001309848, NP_001309849, NP_001350580, NP_001374688, NP_001374689, NP_001374690, NP_001374691, NP_001374692, NP_001374693, NP_001374694, NP_001374695, NP_001374696, NP_001374697, NP_001374698, NP_001374699, NP_001374700, NP_001374701, NP_001374702, NP_689816 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (25 total): zinc finger region 15, cross-link 5, splice variant 2, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N184-F1 | 70.85 | 0.29 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5): 173, 202, 217, 233, 447
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 54 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP, JOHNSTONE_PARVB_TARGETS_3_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CSHL1_TARGET_GENES, SALL4_TARGET_GENES, ZNF26_TARGET_GENES, ZNF486_TARGET_GENES, MIR4795_3P, MIR6809_3P, MIR539_5P, MIR548L
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), regulation of macromolecule metabolic process (GO:0060255), regulation of primary metabolic process (GO:0080090)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| regulation of metabolic process | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| macromolecule metabolic process | 1 |
| primary metabolic process | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
472 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF567 | N4BP2 | Q86UW6 | 543 |
| ZNF567 | SYCE1L | A8MT33 | 490 |
| ZNF567 | ZWILCH | Q9H900 | 486 |
| ZNF567 | ETFB | P38117 | 472 |
| ZNF567 | URB2 | Q14146 | 430 |
| ZNF567 | SPEF1 | Q9Y4P9 | 430 |
| ZNF567 | PRDX6 | P30041 | 427 |
| ZNF567 | DENND2C | Q68D51 | 419 |
| ZNF567 | OSBPL7 | Q9BZF2 | 397 |
| ZNF567 | TMEM131L | A2VDJ0 | 394 |
| ZNF567 | CTTNBP2NL | Q9P2B4 | 375 |
| ZNF567 | RNF144A | P50876 | 375 |
| ZNF567 | FCSK | Q8N0W3 | 368 |
| ZNF567 | LNPK | Q9C0E8 | 367 |
| ZNF567 | DHX35 | Q9H5Z1 | 364 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAP3K20 | ZNF567 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF567 | MAP3K20 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF567 | MAP3K20 | psi-mi:“MI:0915”(physical association) | 0.670 |
| MAP3K20 | ZNF567 | psi-mi:“MI:0915”(physical association) | 0.670 |
| FAM9B | ZNF567 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF567 | HSPD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PCBD1 | ZNF567 | psi-mi:“MI:0915”(physical association) | 0.370 |
| C9orf72 | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF567 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF567 | MAP3K20 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): ZNF567 (Two-hybrid), FAM9B (Two-hybrid), ZNF567 (Two-hybrid), ZAK (Two-hybrid), ZNF567 (Affinity Capture-RNA), ZNF567 (Two-hybrid), ZNF567 (Proximity Label-MS), ZNF567 (Proximity Label-MS), ZNF567 (Affinity Capture-RNA), ZNF567 (Affinity Capture-MS), ZNF567 (Affinity Capture-MS), ZNF567 (Proximity Label-MS), ZNF567 (Positive Genetic), ZNF567 (Affinity Capture-MS), ZNF567 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
53 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1135 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36712509:GTGG:G | donor_gain | 1.0000 |
| 19:36712510:TGG:T | donor_gain | 1.0000 |
| 19:36712511:GG:G | donor_gain | 1.0000 |
| 19:36712511:GGG:G | donor_gain | 1.0000 |
| 19:36712512:GG:G | donor_gain | 1.0000 |
| 19:36712513:G:GC | donor_loss | 1.0000 |
| 19:36712513:G:GG | donor_gain | 1.0000 |
| 19:36712514:T:G | donor_loss | 1.0000 |
| 19:36712773:C:G | acceptor_gain | 1.0000 |
| 19:36712777:TCA:T | acceptor_loss | 1.0000 |
| 19:36712778:CAG:C | acceptor_loss | 1.0000 |
| 19:36712779:A:AG | acceptor_gain | 1.0000 |
| 19:36712779:AG:A | acceptor_gain | 1.0000 |
| 19:36712779:AGG:A | acceptor_gain | 1.0000 |
| 19:36712779:AGGG:A | acceptor_loss | 1.0000 |
| 19:36712779:AGGGT:A | acceptor_gain | 1.0000 |
| 19:36712780:G:A | acceptor_gain | 1.0000 |
| 19:36712780:G:GA | acceptor_gain | 1.0000 |
| 19:36712780:GGG:G | acceptor_gain | 1.0000 |
| 19:36712780:GGGT:G | acceptor_gain | 1.0000 |
| 19:36712780:GGGTG:G | acceptor_gain | 1.0000 |
| 19:36712866:GG:G | donor_gain | 1.0000 |
| 19:36712867:GG:G | donor_gain | 1.0000 |
| 19:36687692:G:GT | donor_gain | 0.9900 |
| 19:36689496:GT:G | donor_gain | 0.9900 |
| 19:36694796:CCTTA:C | acceptor_loss | 0.9900 |
| 19:36694797:CTTA:C | acceptor_loss | 0.9900 |
| 19:36694799:TA:T | acceptor_loss | 0.9900 |
| 19:36694800:A:AT | acceptor_loss | 0.9900 |
| 19:36694801:G:A | acceptor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000058603 (19:36681365 G>A), RS1000097529 (19:36712308 A>G), RS1000145452 (19:36727757 T>C), RS1000257595 (19:36706191 A>G), RS1000302185 (19:36727541 G>A), RS1000341319 (19:36693259 T>C,G), RS1000369494 (19:36675042 T>A,G), RS1000439115 (19:36688806 C>A), RS1000444800 (19:36688546 G>A,T), RS1000515902 (19:36687122 A>C), RS1000547163 (19:36687405 A>C), RS1000632125 (19:36694798 T>C,G), RS1000682160 (19:36680287 A>C,T), RS1000736765 (19:36672568 C>T), RS1000776040 (19:36693803 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, decreases methylation, increases expression | 2 |
| trichostatin A | affects cotreatment, decreases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Valproic Acid | decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| lei gong teng | increases expression | 1 |
| epigallocatechin gallate | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Clorgyline | increases expression | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Succimer | increases expression, affects cotreatment | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Estradiol | affects expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Oxazolone | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.